Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 84Unknown 49Terminated 21Withdrawn 4Recruiting 4Suspended 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Osteosarcoma 1Neoplasm Metastasis 1Adenoma, Islet Cell 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × OTHER × Gefitinib × Clear all
NCT07477457 2026-03-17

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
45 enrolled
Sarcoma

Neoplasm Metastasis, Osteosarcoma

NCT06071013 2025-01-23

Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients

China Medical University Hospital

Phase 1/2 Recruiting
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06592989 2025-01-10

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
20 enrolled

Adenoma, Islet Cell

NCT04322890 2024-10-22

PIKACHU

Hunan Province Tumor Hospital

Phase 2 Recruiting
6,000 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡